IDEAYA Biosciences (IDYA) Enterprise Value (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Enterprise Value of -$671.2 million for Q1 2026, down 4.98% sequentially from -$639.4 million in Q4 2025, and up 35.58% YoY from -$495.1 million in Q1 2025.
IDEAYA Biosciences (IDYA) Enterprise Value (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Enterprise Value for 9 years, with the latest figure at -$671.2 million in Q1 2026.
- Quarterly Enterprise Value rose 35.58% year-over-year to -$671.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$671.2 million (up 35.58% YoY) and the FY2025 annual result came in at -$639.4 million, up 5.46% from the prior year.
- Enterprise Value retreated to -$671.2 million in Q1 2026 per IDYA's latest filing, from -$639.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$252.6 million in Q1 2022 and troughed at -$1.0 billion in Q1 2025.
- A 5-year average of -$582.7 million and a median of -$639.4 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value slumped 105.84% in 2024, then soared 35.58% in 2026.
- Over 5 years, Enterprise Value stood at -$364.8 million in 2022, then plunged by 43.93% to -$525.1 million in 2023, then retreated by 28.79% to -$676.3 million in 2024, then increased by 5.46% to -$639.4 million in 2025, then dropped by 4.98% to -$671.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$671.2 million, -$639.4 million, and -$786.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | -828.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -828.96 Mn |
| Mar 31, 2026 | -671.20 Mn |
| Dec 31, 2025 | -639.39 Mn |
| Sep 30, 2025 | -786.89 Mn |
| Jun 30, 2025 | -669.74 Mn |
| Mar 31, 2025 | -1.04 Bn |
| Dec 31, 2024 | -676.32 Mn |
| Sep 30, 2024 | -920.03 Mn |
| Jun 30, 2024 | -701.66 Mn |
| Mar 31, 2024 | -698.77 Mn |
| Dec 31, 2023 | -525.11 Mn |
| Sep 30, 2023 | -468.75 Mn |
| Jun 30, 2023 | -493.72 Mn |
| Mar 31, 2023 | -339.47 Mn |
| Dec 31, 2022 | -364.83 Mn |
| Sep 30, 2022 | -386.24 Mn |
| Jun 30, 2022 | -268.62 Mn |
| Mar 31, 2022 | -252.60 Mn |
| Dec 31, 2021 | -246.77 Mn |
| Sep 30, 2021 | -264.55 Mn |